The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

People

Professor Terry Nolan AO

Professor Terry Nolan AO

Professor Terry Nolan AO

+61 3 8344 8389 | [email protected]

Position:
Head of Vaccine and Immunisation Research Group
Theme(s):
Immunology, Viral Infectious Diseases
Discipline(s):
Translational and Clinical Research
Unit(s):
The University of Melbourne, Doherty Department
Lab Group(s):
Vaccine and Immunisation Research Group

Professor Terry Nolan AO FAHMS is a paediatrician and clinical epidemiologist, a medical graduate of the University of Western Australia, trained in paediatrics at the Royal Children’s Hospital in Melbourne and at the Montréal Children’s Hospital, with a PhD in epidemiology and biostatistics at McGill University in Montréal. He established the Clinical Epidemiology and Biostatistics Unit at the Royal Children’s Hospital in 1989, was promoted to Professor in 1999 and became Deputy Head of Paediatrics within the School of Medicine, and in 2001 was appointed Foundation Head of the Melbourne School of Population and Global Health. He was Associate Director of the Murdoch Children’s Research Institute in the late 1990s, and has continued an appointment to MCRI as a Professorial Research Fellow and head of the Vaccine and Immunization Research Group (VIRGo) since then. His research has been principally in immunisation and clinical trials of new vaccines. He has over 240 publications in refereed journals. He has considerable experience in working with both Australian and New Zealand Governments and with the World Health Organisation in the provision of policy advice. He served for 9 years on NHMRC’s Research Committee, including a 3-year term as its Deputy Chair. He chaired ATAGI for 9 years. He served a 6-year appointment on the WHO principal global advisory group on immunisation, SAGE (Scientific Advisory Group of Experts).

  • Key Achievements
    Publications
    Loading ORCID data...
    Projects
    • Vaccine and Immunisation Research Group clinical studies

      Mid 2020 - 2021

       

      Current studies

      Quadrivalent cell culture inactivated influenza vaccine Phase III/IV 

      RSV adenovirus vectored vaccine Phase I

      Pneumococcal vaccine 15vPCV Phase III

       

      Planned and possible studies

      Meningococcus MenABCWY Phase III

      Meningococcus MenABCWY Phase III (prior MenACWY)

      Pregnancy RSV vaccine Phase III

      COVID (SARS-CoV-2) vaccines Phase II

      RSV Live-attenuated vaccine Phase II

      Pertussis  Live-attenuated vaccine Phase I/II

    Research Groups
    • Vaccine and Immunisation Research Group

      Based at the Doherty Institute, the Vaccine and Immunisation Research Group (VIRGo) works in partnership with the Murdoch Children’s Research Institute (MCRI, Infection and Immunity Theme). Our research enables us to advise policy makers on the optimal use of vaccines in national immunisation schedules, in pandemic influenza preparedness and response, and in vaccine safety. Our work provides practical bridges (translation) between theory and the real-world delivery of vaccine programs. VIRGo leads Vax4COVID, an alliance of experienced Australian vaccine clinical trial centres formed to facilitate the conduct of Phase II trials of SARS-CoV-2 vaccine candidates. 


      Lab Team

      • Marita Kefford
        Research Manager
      • Dr Briony Price
        Senior Research Officer
      • Dr Maryanne Griffith
        Business Development Officer
      • Dr Lana Horng
        Study Doctor
      • Clare Brophy
        Research Assistant
      • Janet Briggs
        Research Assistant
      • Annmarie McEvoy
        Research Assistant
      • Jane Ryrie
        Research Assistant
      • Samara Griffin
        Research Assistant
      • Anna Bourke
        Research Assistant
      • Bernie McCudden
        Phlebotomist
      • Catherine Sheehan
        Phlebotomist